This medication is typically recommended for individuals with a BMI of 30 or higher or a BMI of 27 or higher with comorbidities such as diabetes
As a game-changing new class of injectable diabetes and obesity drugs surges in popularity, widespread shortages and steep prices for brand-name GLP-1 drugs which also include Mounjaro and Zepbound have persisted, pushing droves of weight-loss hopefuls into a booming, less regulated secondary market for copies that are more affordable and readily available online
As use grows, some people are noticing an unexpected change: their menstrual cycles
Heres what we know and what we dont know yet
Clinical trials have shown that Semaglutide is highly effective for weight management, with participants losing a significant amount of weight after weeks of consistent treatment
Other common eye problems beyond headache-causing conditions include conjunctivitis, cataracts, macular degeneration, diabetic retinopathy, and presbyopia
